Product correctly added to cart.

discount label
IFNG antibody
View 3D

Biosynth logo

IFNG antibody

Ref. 3D-70R-15388

100µg
515.00 €
Estimated delivery in United States, on Monday 13 Jan 2025

Product Information

Name:
IFNG antibody
Description:

The 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is a powerful antituberculosis drug belonging to the class of rifamycins. This active compound is highly effective in treating tuberculosis infections. By binding to DNA-dependent RNA polymerase, it inhibits bacterial growth, preventing transcription and replication. Its bactericidal activity has been demonstrated through patch-clamp technique on human erythrocytes. Metabolized through various transformations, including hydrolysis, oxidation, reduction, and conjugation, this drug specifically targets Mycobacterium tuberculosis strains and inhibits cell growth. With its potent properties and targeted approach, the 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is an excellent choice for combating tuberculosis infections.

Tilmicosin is a macrolide antibiotic widely used in veterinary medicine to treat respiratory disorders in animals caused by bacteria such as Clostridium perfringens. By

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-70R-15388 IFNG antibody

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".